Department of Physiology and Pharmacology, Oregon Health and Science University, Portland, 97239, USA.
Endocrinology. 2012 Nov;153(11):5659-67. doi: 10.1210/en.2012-1254. Epub 2012 Sep 4.
3-Iodothyronamine (T(1)AM) is an endogenous thyroid hormone derivative with unknown biosynthetic origins. Structural similarities have led to the hypothesis that T(1)AM is an extrathyroidal metabolite of T(4). This study uses an isotope-labeled T(4) [heavy-T(4) (H-T(4))] that can be distinguished from endogenous T(4) by mass spectrometry, which allows metabolites to be identified based on the presence of this unique isotope signature. Endogenous T(1)AM levels depend upon thyroid status and decrease upon induction of hypothyroidism. However, in hypothyroid mice replaced with H-T(4), the isotope-labeled H-T(3) metabolite is detected, but no isotope-labeled T(1)AM is detected. These data suggest that T(1)AM is not an extrathyroidal metabolite of T(4), yet is produced by a process that requires the same biosynthetic factors necessary for T(4) synthesis.
3-碘代甲状腺原氨酸(T(1)AM)是一种内源性甲状腺激素衍生物,其生物合成来源未知。结构上的相似性导致了 T(1)AM 是 T(4)的甲状腺外代谢产物的假说。本研究使用一种同位素标记的 T(4) [重-T(4)(H-T(4))],可以通过质谱法与内源性 T(4)区分开来,这使得可以根据这种独特的同位素特征的存在来识别代谢产物。内源性 T(1)AM 水平取决于甲状腺状态,并在诱导甲状腺功能减退时降低。然而,在接受 H-T(4)替代的甲状腺功能减退小鼠中,检测到同位素标记的 H-T(3)代谢产物,但未检测到同位素标记的 T(1)AM。这些数据表明,T(1)AM 不是 T(4)的甲状腺外代谢产物,但它的产生过程需要与 T(4)合成相同的生物合成因素。